Navigation Links
Amylin Pharmaceuticals Reports 2007 Financial Results
Date:1/28/2008

06. The increase reflects higher cost-sharing payments to equalize development expenses for BYETTA and exenatide once weekly and $15 million in milestones associated primarily with the launch of BYETTA in the European Union during the second quarter of 2007.

Selling, general and administrative expenses increased to $391.0 million for the year ended December 31, 2007, compared to $282.0 million for the same period in 2006. The increase reflects increased promotional expenses for BYETTA and SYMLIN, costs associated with the Company's expanded field force, and increased business infrastructure to support the Company's growth.

Research and development expenses increased to $276.6 million for the year ended December 31, 2007 compared to $222.1 million for the same period in 2006. The increase primarily reflects costs associated with the development of exenatide once weekly.

Collaborative profit sharing, which represents Lilly's 50% share of BYETTA gross margin, was $290.9 million for the year ended December 31, 2007 compared to $194.2 million for the same period in 2006.

Net loss for the year ended December 31, 2007 was $211.1 million, or $1.59 per share, compared to $218.9 million, or $1.78 per share for the same period in 2006.

Conference Call

Amylin will webcast its Quarterly Update Conference Call today at 5:00 p.m. ET/2:00 p.m. PT. The call will be webcast live through Amylin's corporate website, http://www.amylin.com, and a recording will be made available following the close of the call.

Daniel M. Bradbury, Amylin's President and Chief Executive Officer, will lead the call. During the call, the Company plans to provide further details underlying its fourth quarter and 2007 financial results, and information regarding guidance for 2008 operations. For those without access to the Internet, the live call may be accessed by phone by calling (800) 901-5231 (domestic) or (
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Xenome Enters Into Joint Research Collaboration to Discover Novel Peptide Therapeutics with Amylin Pharmaceuticals
2. Amylin Pharmaceuticals to Present at Research & Development Day
3. Amylin Pharmaceuticals to Webcast Conference Call
4. Amylin Pharmaceuticals to Webcast Third Quarter Results
5. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
6. MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity
7. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
8. Wyeth and Teva Pharmaceuticals Extend the Standstill Period Relating to Tevas Launch of Generic Pantoprazole
9. Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger With Nycomed
10. MAP Pharmaceuticals Reaches Agreement with FDA on Special Protocol Assessment for MAP0004 Phase 3 Clinical Trial in Patients With Migraine
11. Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2015)... 2015 The culmination of one of the ... the Final Four invades Lucas Oil Stadium in ... one filled with excitement, buzzer-beaters, and of course, upsets. Throughout ... have been made, and future professional products have been seen. ... the four teams that advanced through their regional bracket with ...
(Date:3/29/2015)... (PRWEB) March 29, 2015 The ... ( http://www.testosteronelawsuithub.com/ ) pending in the U.S. District ... litigation’s next Case Management Conference for April 21st ... meeting will address the progress of product liability ... experienced heart attacks, strokes and other cardiovascular complications ...
(Date:3/29/2015)... (PRWEB) March 29, 2015 Final ... new transition from Pixel Film Studios, entitled TranSports. ... made exclusively for Final Cut Pro X,” said Christiana ... users the tools needed to effortlessly transition using this ... TranSports, a new and uniquely styled transition pack for ...
(Date:3/28/2015)... Rocket Pure , a manufacturer of natural body care ... natural sunscreen. They are offering the sunscreen in both ... with a bonus lip balm sunscreen. , The new products ... Click to see the natural sunscreen on Amazon . , ... with non-nano zinc oxide and provides broad-based protection against UVA ...
(Date:3/28/2015)... "Necrorun" was featured on NewsWatch as ... at the latest and coolest applications on the market ... of NewsWatch and technology expert, conducted the app review ... endless runner game with knights, nature, and peasants. ... 2009, according to Eurogamer. The popularity of these games ...
Breaking Medicine News(10 mins):Health News:Cheap 2015 Final Four Tickets: Ticket Down Slashes Kentucky Wildcats and Wisconsin Badgers Final Four Tickets at Lucas Oil Stadium and Issues Valuable Promo Code 2Health News:Federal Court Overseeing Testosterone Treatment Lawsuits Schedules April Case Management Conference 2Health News:Federal Court Overseeing Testosterone Treatment Lawsuits Schedules April Case Management Conference 3Health News:Introducing TranSports for Final Cut Pro X Users from Pixel Film Studios 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 3Health News:A Grim Endless Runner Game Was Featured on NewsWatch Television on January 30, 2015 2
... Baiganwadi slum at Govandi is becoming a source of fright ... polio cases have been reported in 2 weeks from this ... contaminated with dengue transmitting Aedes aegypti mosquitoes and malarial parasites. ... has taken 3 lives in this area; 2 in September ...
... have arrived in Bahrain to receive urgently needed medical treatment.// ... coming days as part of an agreement with the World ... response to a call to help fund treatment for seriously ... is the head of the newly established Organisation for Culturing ...
... labourers coming home for the festive season comprise most of ... afflicted with the mosquito-borne virus so far.// ,State ... in the state. ,Most of the suspected dengue ... places like Delhi, Rajasthan, Haryana and Uttar Pradesh for the ...
... recorded by an unsteadily held camera, one can feel nauseous. ... almost continuous shaky video stream from our eyes which is ... our bodies which is in constant motion at any given ... for Biological Studies have found that the brain not only ...
... backlogs of patients for important surgeries has alerted ... the issue. According to the complaint, operations ... been put on the back burner, with patients ... of evidence to support these complaints has spurred ...
... three-year, $728,000 grant from the US Department of Health ... School of Nursing has established a new palliative care ... Palliative care nursing provides care for patients with serious ... first college or university in New England to offer ...
Cached Medicine News:Health News:A slum in Mumbai – breeding ground for disease 2Health News:Migrant Bihar Labourers Bring Dengue Home 2Health News:Perception Stabilized – Thanks to Your Brains 2Health News:Perception Stabilized – Thanks to Your Brains 3Health News:College Launches Palliative Care Nursing Program 2
(Date:3/27/2015)... , March 27, 2015 Concord ... "Company") (NYSE: CCM ), a leading specialty ... largest network of radiotherapy and diagnostic imaging centers ... the signing of a purchase agreement under which ... owned subsidiary of the Company, agreed to acquire ...
(Date:3/26/2015)... ON , March 26, 2015 /PRNewswire/ - Pivotal Therapeutics ... pharmaceutical company with a focus on Omega-3 therapies for ... 25, 2015 it issued 763,752 common shares of the ... of interest for the period of December 5 th ... its outstanding Convertible Notes that is due on or ...
(Date:3/26/2015)... March 26, 2015  OncoGenex Pharmaceuticals, Inc. (NASDAQ: ... clinical developments and announced fourth quarter and year ... Developments and Anticipated Near-term MilestonesCustirsen , ... to negotiate the termination of their collaboration and ... final termination agreement are ongoing. , Two ...
Breaking Medicine Technology:Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 2Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 3Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 3OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 4OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 5OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 6OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 7OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 8
... announced today that it has updated coverage on ... Company")and maintains its twelve month target price of $6.50. Ross ... Company, Opexa,s lead clinical candidate Tovaxin®, an autologous cellular immunotherapy ... to advance into a pivotal Phase 3 clinical study in ...
... Electronics, a San Jose, California based cable and harness assembly ... in San Jose, CA.  The company will add another 12,500 ... stay ahead of our customers, needs and these new initiatives ... that," says VP of Operations, Ruben Macias. The plant expansion ...
Cached Medicine Technology:Vista Partners Updates Coverage on Opexa Therapeutics, Inc.; Maintains Target Price of $6.50 2DC Electronics Expands Facilities to Increase Capacity 2
... Includes base with vacuum stage, porous vacuum ... gaskets, lid, instructions. The Model 785 vacuum ... from an agarose gel onto a nylon membrane. ... transfer, the nucleic acid samples can be separated ...
Mini Trans-Blot and PowerPac 300 System, 110-120 V...
Inquire...
... Blotting System. Designed for Western, ... up to three gels with dimensions ... Includes and internal cooling base ... cover with attached power leads. ...
Medicine Products: